About U-Needle
U-Needle is a company based in Enschede (Netherlands) founded in 2008 by Jeroen M. Wissink. U-Needle has raised $5.7 million across 1 funding round from investors including Holland Capital and Waterman Ventures. U-Needle offers products and services including Bella-mu and Bella-Vue. U-Needle operates in a competitive market with competitors including Owen Mumford, Flat Medical, Retractable Technologies, KORU Medical Systems and NuGen MD, among others.
- Headquarter Enschede, Netherlands
- Founders Jeroen M. Wissink
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.7 M (USD)
in 1 rounds
-
Latest Funding Round
$5.7 M (USD), Series A
Sep 28, 2020
-
Investors
Holland Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of U-Needle
U-Needle offers a comprehensive portfolio of products and services, including Bella-mu and Bella-Vue.
Facilitates intradermal administration for vaccines and drug delivery.
Enables precise delivery of therapies to the back of the eye.
Funding Insights of U-Needle
U-Needle has successfully raised a total of $5.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.7 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in U-Needle
U-Needle has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Holland Capital and Waterman Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Holland Capital is engaged in venture and growth investments.
|
Locked | Locked | Locked | |
|
Waterman Ventures is focused on supporting innovative growing businesses.
|
Locked | Locked | Locked |
Investor details for U-Needle
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by U-Needle
Investment portfolio details for U-Needle
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - U-Needle
Detailed financials for U-Needle
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
U-Needle Comparisons
Peer comparison for U-Needle
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of U-Needle
U-Needle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owen Mumford, Flat Medical, Retractable Technologies, KORU Medical Systems and NuGen MD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Disposables for drug delivery and capillary blood sampling are manufactured.
|
|
| Locked | Locked | Locked |
Epidural injection syringes with pressure detection are manufactured.
|
|
| Locked | Locked | Locked |
Provides portfolio of smart syringes and needles to prevent from needle-stick injuries
|
|
| Locked | Locked | Locked |
Infusion systems and accessories for subcutaneous drug administration are manufactured.
|
|
| Locked | Locked | Locked |
Developer of needle-free drug delivery system
|
Detailed competitors of U-Needle
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on U-Needle
Complete news archive for U-Needle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about U-Needle
U-Needle was founded in 2008 and raised its 1st funding round 12 years after it was founded.
U-Needle is headquartered in Enschede, Netherlands. It is registered at Enschede, Overijssel, Netherlands.
Jeroen M. Wissink is the current CEO of U-Needle. They have also founded this company.
U-Needle is a funded company, having raised a total of $5.7M across 1 funding round to date.
U-Needle was established in 2008 in Enschede, Netherlands, within the medical device sector. Silicon microneedles for intradermal injections are produced by the company. The Bella-mu product is utilized for drug delivery applications in vaccination and aesthetic procedures via the Mantoux technique. Dendritic cells in the immune system are targeted through this injection technology, with reductions in anxiety and pain observed during use.
U-Needle's top competitors include KORU Medical Systems, Stable Pharma and Flat Medical.
U-Needle offers Bella-mu and Bella-Vue.
U-Needle has 2 investors. Key investors include Holland Capital, and Waterman Ventures.